Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-14 9:55 pm Purchase | 2025-06-30 | 13G | TransCode Therapeutics, Inc. RNAZ | Anson Funds Management LP | 27,125 0.100% | 23,072 (+569.29%) | Filing History |
| 2025-08-14 9:53 pm Purchase | 2025-06-30 | 13G | NRx Pharmaceuticals, Inc. NRXP | Anson Funds Management LP | 1,604,975 9.300% | 425,914 (+36.12%) | Filing History |
| 2025-08-14 9:51 pm Purchase | 2025-06-30 | 13G | 22nd Century Group, Inc. XXII | Anson Funds Management LP | 602,654 4.900% | 594,998 (+7771.39%) | Filing History |
| 2025-08-14 9:51 pm Purchase | 2025-06-30 | 13G | Chanson International Holding CHSN | Anson Funds Management LP | 48,704 9.900% | 48,704 (New Position) | Filing History |
| 2025-08-14 9:51 pm Purchase | 2025-06-30 | 13G | Yorkville Acquisition Corp. YORK | Anson Funds Management LP | 1,276,808 8.300% | 1,276,808 (New Position) | Filing History |
| 2025-08-14 9:50 pm Sale | 2025-06-30 | 13G | Greenwave Technology Solutions, Inc. GWAV | Anson Funds Management LP | 29,206 4.900% | -14,823 (-33.67%) | Filing History |
| 2025-08-14 9:48 pm Purchase | 2025-06-30 | 13G | Digital Ally, Inc. DGLY | Anson Funds Management LP | 47,117 0.030% | 47,117 (New Position) | Filing History |
| 2025-08-14 9:48 pm Sale | 2025-06-30 | 13G | Spero Therapeutics, Inc. SPRO | Anson Funds Management LP | 1,615,469 2.900% | -2,134,981 (-56.93%) | Filing History |
| 2025-08-14 9:47 pm Sale | 2025-06-30 | 13G | FEMTO TECHNOLOGIES INC FMTOF | Anson Funds Management LP | 0 0.000% | -324,808 (Position Closed) | Filing History |
| 2025-08-14 9:45 pm Purchase | 2025-06-30 | 13G | Oblong, Inc. OBLG | Anson Funds Management LP | 147,055 9.900% | 147,055 (New Position) | Filing History |
| 2025-08-14 9:43 pm Sale | 2025-06-30 | 13G | SELLAS Life Sciences Group, Inc. SLS | Anson Funds Management LP | 5,225,948 4.900% | -2,353,147 (-31.05%) | Filing History |
| 2025-08-14 9:42 pm Purchase | 2025-06-30 | 13G | Applied DNA Sciences, Inc. APDN | Anson Funds Management LP | 573,538 8.200% | 364,069 (+173.81%) | Filing History |
| 2025-08-14 9:41 pm Sale | 2025-06-30 | 13G | Hepion Pharmaceuticals, Inc. HEPA | Anson Funds Management LP | 576,482 4.900% | -19,237 (-3.23%) | Filing History |
| 2025-08-14 9:37 pm Purchase | 2025-06-30 | 13G | Nano Labs Ltd NA | Anson Funds Management LP | 1,808,440 8.700% | 1,808,440 (New Position) | Filing History |
| 2025-07-24 3:53 pm Unchanged | 2025-07-22 | 13D | MEI Pharma, Inc. MEIP | Anson Funds Management LP | 1,093,188 3.700% | 0 (Unchanged) | Filing History |
| 2025-07-14 5:42 pm Sale | 2025-07-11 | 13D | Nano Dimension Ltd. NNDM | Anson Funds Management LP | 9,057,952 4.200% | -7,303,481 (-44.64%) | Filing History |
| 2025-07-03 6:54 pm Sale | 2025-06-26 | 13D | Nano Dimension Ltd. NNDM | Anson Funds Management LP | 16,361,433 7.500% | -4,029,780 (-19.76%) | Filing History |
| 2025-05-15 6:07 pm Purchase | 2025-03-31 | 13G | Universe Pharmaceuticals Inc. UPC | Anson Funds Management LP | 234,374 1.000% | 214,816 (+1098.34%) | Filing History |
| 2025-05-15 5:23 pm Purchase | 2025-03-31 | 13G | Hepion Pharmaceuticals, Inc. HEPA | Anson Funds Management LP | 595,719 9.900% | 595,538 (+328311.63%) | Filing History |
| 2025-05-15 5:15 pm Purchase | 2025-03-31 | 13G | NRx Pharmaceuticals, Inc. NRXP | Anson Funds Management LP | 1,179,061 7.000% | 1,179,061 (New Position) | Filing History |